Lectin‐complement pathway molecules are decreased in patients with cirrhosis and constitute the risk of bacterial infections
- 28 February 2017
- journal article
- research article
- Published by Wiley in Liver International
- Vol. 37 (7) , 1023-1031
Abstract
Background & Aims: Lectin pathway molecules of the complement system are synthesized by hepatocytes and have pivotal role in innate host defence against infectious organisms. Ficolins (FCNs) act as soluble pattern recognition molecules, while mannan‐binding lectin serine proteases(MASPs) do as effector molecules in elimination of pathogens. We aimed to study the significance of low level of these molecules in the development of cirrhosis‐associated bacterial infections, which has not been elucidated so far.Methods: Sera of 266 stable outpatients with cirrhosis and 160 healthy subjects were assayed for a panel of lectin molecules (FCN‐2, FCN‐3 and MASP‐2) by ELISA. In cirrhosis, a 5‐year follow‐up observational study was conducted to assess a possible association between lectin levels and development of clinically significant bacterial infections(CSI).Results: FCN‐2, FCN‐3 and MASP‐2 levels were significantly lower in cirrhosis compared to healthy subjects and decreased according to disease severity (P<.001 for all molecules). In Kaplan‐Meier analysis, development of CSI was associated with low level of FCN‐2 (pLogRank=0.047) and FCN‐3 (pLogRank=0.029), but not with MASP‐2 deficiency (pLogRank=0.306). Combined FCN deficiency was associated with increased risk of development of bacterial infections in a step‐wise manner. Patients with low level of both FCNs had higher cumulative probability of CSI (63.8%) compared to those with low level of one or normal FCN (52.7% and 45.7%, pLogRank=0.016). Neither FCN serum profile, nor MASP‐2 deficiency were associated with infection‐related mortality.Conclusions: Low level of FCNs associated with hepatic insufficiency might be considered as an additional constituent of cirrhosis‐associated immune dysfunction.Keywords
Funding Information
- Emberi Eroforrások Minisztériuma (ÚNKP‐16‐3)
This publication has 33 references indexed in Scilit:
- Phenotypic polymorphism of haptoglobin: A novel risk factor for the development of infection in liver cirrhosisHuman Immunology, 2011
- Infections in Patients With Cirrhosis Increase Mortality Four-Fold and Should Be Used in Determining PrognosisGastroenterology, 2010
- Mannose-binding lectin deficiency confers risk for bacterial infections in a large Hungarian cohort of patients with liver cirrhosisJournal of Hepatology, 2010
- Toll‐like receptor 4 D299G polymorphism and the incidence of infections in cirrhotic patientsAlimentary Pharmacology & Therapeutics, 2010
- Nucleotide‐binding oligomerization domain containing 2 (NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis†Hepatology, 2010
- Störungen des angeborenen Immunsystems bei akuten und chronischen LebererkrankungenWiener klinische Wochenschrift, 2009
- Bacterial Infections, Sepsis, and Multiorgan Failure in CirrhosisSeminars in Liver Disease, 2008
- Infection, coagulation, and variceal bleeding in cirrhosisGut, 2005
- Antibiotic Prophylaxis for the Prevention of Bacterial Infections in Cirrhotic Patients With Gastrointestinal Bleeding: A Meta–AnalysisHepatology, 1999
- A prospective study of bacterial infections in patients with cirrhosisJournal of Hepatology, 1993